Recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors NCT06730347 Conditions Clear Cell Adenocarcinoma of Cervix, Clear Cell Adenocarcinoma of Fallopian Tube, Clear Cell Adenocarcinoma of Ovary, +20 more Locations UCLA — Los Angeles, California, United States Ochsner MD Anderson Cancer Center — New Orleans, Louisiana, United States START Midwest — Grand Rapids, Michigan, United States West Penn Allegheny Health — Pittsburgh, Pennsylvania, United States View all 16 locations View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression NCT07168083 Conditions Adnexal Diseases, Antibody-drug Conjugates, Clear Cell Adenocarcinoma of Ovary, +15 more Locations Not specified View Trial Details
